Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MONITOR-AF: Spironolactone for Atrial Fibrillation
NCT04327232Phase 2Unknown
- Sponsor
- National University Hospital
- Start
- May 2018
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of spironolactone in Atrial fibrillation (AFib), sponsored by National University Hospital. Status: unknown.
02
Drugs
spironolactone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT04327232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04327232.